Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q1 EPS of ($1.42), $0.44 worse than the analyst estimate of ($0.98).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.